Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.65 USD | -8.78% | -24.00% | -64.44% |
Business Summary
Number of employees: 11
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 08-04-30 | |
Melissa Gaines
CTO | Chief Tech/Sci/R&D Officer | - | - |
Cheng Fang
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-17 |
Andrew Walsh
PRN | Corporate Officer/Principal | - | Nov. 30 |
Eve M. Damiano
LAW | General Counsel | - | 21-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Hoffman
CHM | Chairman | 73 | 13-12-31 |
Chief Executive Officer | 73 | 08-04-30 | |
Reid McCarthy
BRD | Director/Board Member | 70 | 21-04-08 |
Claudine Bruck
BRD | Director/Board Member | 68 | 14-12-31 |
Mark White
BRD | Director/Board Member | 68 | 15-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,171,480 | 8,356,522 ( 74.80 %) | 0 | 74.80 % |
Company contact information
Annovis Bio, Inc.
101 Lindenwood Drive Suite 225
19355, Malvern
+(484) 875-3192
http://www.annovisbio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.44% | 81.44M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- ANVS Stock
- Company Annovis Bio, Inc.